DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Vomiting - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Vomiting (79)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 79   Next >>

Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Fatigue, Vomiting, Pruritus, Diarrhoea, Dehydration, Ephelides

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Start date: 2012-03-24

Rebetol
    Dosage: 1200 mg, qd
    Administration route: Oral
    Start date: 2012-03-24

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Other drugs received by patient: Metformin HCL



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: White Blood Cell Count Decreased, Dyspnoea, Vomiting, RED Blood Cell Count Decreased, Nausea, Dizziness, Pallor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-10-21

Rebetol
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2011-10-21

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-10-21



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, Oral Mucosal Blistering, Vomiting, LIP Blister, Nausea, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2012-08-17
    End date: 2012-08-19

Rebetol



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Vomiting

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    End date: 2012-04-16

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-03-14
    End date: 2012-04-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-12
    End date: 2012-04-16

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-04-11

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-04-12

Telavic
    Dosage: 1750 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-13

Other drugs received by patient: Dextrose (+) Electrolytes (Unspecified) (+) Sodium Lactate; Cyanocobalamin (+) Pyridoxine Hydrochloride (+) Thiamine Disulfide; Urso 250; Amino Acids (Unspecified); Fladd; Amlodipine Besylate; Selbex; Myser (Cycloserine); Ascorbic Acid; Olopatadine HCL; Neomallermin TR; Marzulene ES; Lansoprazole; Ascorbic Acid (+) Vitamin B Complex



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-05-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Telavic
    Dosage: 2250 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-25

Telavic
    Dosage: 1000 unk, unk,cumulative dose 4500 mg
    Start date: 2012-06-13
    End date: 2012-07-09

Telavic
    Dosage: 1500 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-06-12

Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Stomatitis, Vomiting, Diarrhoea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-08-01

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-05



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Vomiting, Renal Disorder, Nausea

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Investigational Drug (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Investigational Drug (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-04

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-28

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-24
    End date: 2012-02-24

Peginterferon Alfa-2B
    Dosage: 80 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-23

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Rebetol
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Telavic
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-26

Telavic
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Telavic
    Administration route: Oral
    Start date: 2012-04-04

Telavic
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Other drugs received by patient: Warfarin Sodium; Urso 250; Digoxin; Urso 250; Nizatidine; Efonidipine Hydrochloride Ethanolate; Nizatidine; Diovan



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-13

Patient:

Reactions: Vomiting, Drug Ineffective, Pain in Extremity, Somnolence, Ulcer, Diarrhoea, Blood Potassium Decreased, Dehydration

Drug(s) suspected as cause:
Intron A
    Dosage: unk unk, q3w
    Indication: Hepatitis C
    Start date: 2001-09-28
    End date: 2002-09-27

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2001-09-28
    End date: 2002-09-27



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Vomiting, Dehydration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, unk

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-10

Patient:

Reactions: White Blood Cell Count Decreased, Dysgeusia, Weight Decreased, Vomiting, Nausea, Dehydration, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-01

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-01



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Vomiting, Nausea, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.725mcg/kg/week
    Start date: 2012-06-28

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-24
    End date: 2012-06-21

Rebetol
    Administration route: Oral
    Start date: 2012-06-28

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-24
    End date: 2012-06-27

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-24
    End date: 2012-06-20

Telavic
    Administration route: Oral
    Start date: 2012-06-21

Other drugs received by patient: Amoban



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Viral Load Increased, Vomiting, Contusion, Paranoia, Hyperhidrosis, Polyneuropathy, Joint Stiffness, Hallucination, Visual, Diarrhoea, Treatment Failure, Infection

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2008-01-01
    End date: 2008-07-01

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-12-01
    End date: 2007-08-01

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-12-01
    End date: 2007-08-01

Rebetol
    Dosage: unk
    Start date: 2008-01-01
    End date: 2008-07-01



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-09

Patient:

Reactions: Vomiting, Dizziness, Hypoaesthesia, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-10

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-05-27

Rebetol
    Administration route: Oral
    Start date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-05-28
    End date: 2012-06-03

Telavic
    Administration route: Oral
    Start date: 2012-06-05

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-06-03

Other drugs received by patient: Amlodipine Besylate; Famotidine; Laxoberon; Pursennid (Sennosides); Loxonin; Mucosta; Juvela; Evamyl; Aspirin



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Weight Decreased, Fatigue, Vomiting, Chills, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-13

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-13

Victrelis
    Indication: Hepatitis C

Other drugs received by patient: Zofran



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-07

Patient:

Reactions: Weight Decreased, Dysgeusia, Vomiting, Fatigue, Arthralgia, Alopecia, Chromaturia, Rash, Muscle Twitching

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, qm
    Indication: Hepatitis C
    Start date: 2012-05-23

Rebetol
    Dosage: 200 mg, unk

Victrelis
    Dosage: 200 mg, unk



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Weight Decreased, Fatigue, Vomiting, Pruritus, Nausea, Chills, Urticaria, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-13

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-13

Other drugs received by patient: Zofran



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: White Blood Cell Count Decreased, Weight Decreased, Skin Injury, Vomiting, Drug Ineffective, Tooth Extraction, Tooth Infection, Headache, Haematemesis, Pain in JAW

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-05

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-05

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-03
    End date: 2012-07-06



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-04

Patient:

Reactions: Vomiting, Nausea, Diarrhoea, Alopecia, Headache

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 microgram, unk
    Start date: 2012-03-20
    End date: 2012-07-01

Rebetol
    Dosage: 400 mg, qpm
    Start date: 2012-03-20
    End date: 2012-07-01

Rebetol
    Dosage: 600 mg, qam
    Start date: 2012-03-20
    End date: 2012-07-01

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-24
    End date: 2012-07-01



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-07-31

Patient:

Reactions: Aphagia, Vomiting, Diarrhoea, Hypokalaemia, Loss of Consciousness

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-04-26

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-04-26



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-30

Patient:

Reactions: Drug Eruption, Vomiting, Renal Impairment, Pruritus, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.0mcg/kg
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-21

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-18

Other drugs received by patient: Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto; Norvasc; Maglax (Magnesium Oxide); Flavitan



Possible Rebetol side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Bedridden, Chest Discomfort, Vomiting, Nausea, Retching, Anaemia, Oropharyngeal Pain, Pyrexia, DRY Skin, Anxiety, Weight Increased, Thinking Abnormal, Dehydration

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-31

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-31

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-28



Possible Rebetol side effects in

Reported by a physician from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-06-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-08
    End date: 2012-06-29



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient:

Reactions: Weight Decreased, Vomiting, Fatigue

Drug(s) suspected as cause:
Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-06-12

Other drugs received by patient: Pegasys



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Vomiting, Nausea, Anaemia, Headache, Scan Brain, Eating Disorder, Abdominal Pain Upper, Neck Pain, Vasculitis, Memory Impairment, Feeling Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-09

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-09



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-13

Patient:

Reactions: Vomiting, Loss of Consciousness

Drug(s) suspected as cause:
PEG-Intron

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-13

Patient:

Reactions: Vomiting, Nausea, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-09

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-06-01

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-02

Telaprevir
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-06-07

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-17

Other drugs received by patient: Micardis; Sefirom



Possible Rebetol side effects in 49 year old female

Reported by a physician from France on 2012-07-05

Patient: 49 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Productive Cough, Food Intolerance, Vomiting, Nausea, Hyperthermia, Anaemia, Pyrexia, Lung Disorder, Gastrointestinal Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neorecormon (Epoetin Beta)
    Dosage: 30000 iu; biw
    Start date: 2012-04-26

Rebetol
    Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
    Indication: Hepatitis C
    Start date: 2012-06-20

Rebetol
    Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
    Indication: Hepatitis C
    Start date: 2012-03-16

Rebetol
    Dosage: 800 mg;qd; 600 mg; qd; 400 mg; qd
    Indication: Hepatitis C
    Start date: 2012-06-07

Victrelis
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-22

Viraferonpeg
    Dosage: 80 mcg; qw;
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-06-22

Other drugs received by patient: Drospirenone and Ethinyl Estradiol; Dexeryl; Isentress; Fortimel; Celluvisc; Mycoster; Viread; Emtriva; Acetaminophen



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017